文献速递衰弱、肌少症与跌倒老年慢病共病管理

白蛋白联合传统风险评分可改善TAVR术后死亡预测

Addition of albumin to Traditional Risk Score Improved Prediction of Mortality in Individuals Undergoing Transcatheter Aortic Valve Replacement.
PubMed 文献 · J Am Geriatr Soc · 2017-09-23

本研究为回顾性分析,纳入426例接受经导管主动脉瓣置换术(TAVR)的患者,比较基线血清白蛋白中位数(4 g/dL)、STS评分(4.5%)和EuroSCORE-2(3.45%)分组的生存率。结果显示低白蛋白者死亡风险更高(HR=3.03),且白蛋白联合STS或EuroSCORE-2可显著改善死亡风险分类(NRI分别为0.58和0.64)。

要点

  • 低基线血清白蛋白与TAVR术后死亡率升高相关(HR=3.03)。
  • 低白蛋白合并高STS或EuroSCORE-2评分者死亡风险进一步增加。
  • 白蛋白加入STS或EuroSCORE-2可改善死亡风险分类能力。

核心结论

  • 血清白蛋白作为衰弱标志物可显著提高STS和EuroSCORE-2评分对TAVR相关死亡的预测能力。

研究设计与样本

  • 回顾性分析,基于三级医院前瞻性注册登记,纳入426例接受TAVR的患者。

主要发现

  • 低白蛋白水平者死亡率更高(HR=3.03,95%CI=1.66-5.26,P<.001)。
  • 低白蛋白且高STS评分者死亡率更高(HR=4.55,95%CI=2.21-9.38,P<.001)。
  • 低白蛋白且高EuroSCORE-2评分者死亡率更高(HR=2.72,95%CI=1.48-5.06,P=.001)。
  • 白蛋白联合STS的模型正确重分类42%的事件(NRI=0.58)。
  • 白蛋白联合EuroSCORE-2的模型正确重分类44%的事件(NRI=0.64)。

关键数值与推荐

  • 基线血清白蛋白中位数4 g/dL,STS评分中位数4.5%,EuroSCORE-2中位数3.45%。
  • 按白蛋白和评分中位数高低分为四组比较1年生存率。
  • 使用无类别净重分类指数(NRI)比较模型分类能力。

临床怎么用

  • 在TAVR术前风险评估中,可考虑将血清白蛋白作为衰弱标志物加入STS或EuroSCORE-2评分以改善死亡风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The ability of the Society of Thoracic Surgeons (STS) and European System for Cardiac Operative Risk Evaluation (EuroSCORE)-2 scores to predict outcomes after transcatheter aortic valve replacement (TAVR) is insufficient. Frailty and serum albumin as a frailty marker were shown to correlate with prognosis after TAVR. We sought to evaluate the additive value of serum albumin to STS and EuroSCORE-2 scores to predict mortality in individuals undergoing TAVR. DESIGN: Retrospective analysis. SETTING: Tertiary-care hospital prospective registry. PARTICIPANTS: Individuals who underwent TAVR (N = 426). MEASUREMENTS: We compared survival rates according to median baseline albumin levels (4 g/dL), STS score (4.5%), and EuroSCORE-2 (3.45%). Participants were divided into four groups according to median serum albumin and median STS and EuroSCORE-2 scores (high vs low), and 1-year survival rates were compared. A category-free net reclassification index (NRI) was calculated to compare the ability of a model of STS or EuroSCORE-2 alone to classify mortality risk with and without the addition of baseline serum albumin. RESULTS: Participants with low albumin levels had higher mortality (hazard ratio (HR) = 3.03, 95% confidence interval (CI) = 1.66-5.26, P < .001). Participants with low serum albumin and a high STS (HR = 4.55, 95% CI = 2.21-9.38, P < .001) or EuroSCORE-2 (HR = 2.72, 95% CI = 1.48-5.06, P = .001) score had higher mortality. Using NRI analysis, a model that included albumin in addition to STS correctly reclassified 42% of events (NRI = 0.58) and a model that included albumin in addition to EuroSCORE-2 correctly reclassified 44% of events (NRI = 0.64). CONCLUSION: Serum albumin, as a marker of frailty, can significantly improve the ability of STS and EuroSCORE-2 scores to predict TAVR-related mortality.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Grossman Y, Barbash IM, Fefer P, et al. Addition of albumin to Traditional Risk Score Improved Prediction of Mortality in Individuals Undergoing Transcatheter Aortic Valve Replacement. J Am Geriatr Soc. 2017. PMID: 28941287. doi:10.1111/jgs.15070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。